We collect and use information about you, your devices and interactions to improve our services. For more information about how we collect your personal information and our use of cookies on our website, please see our Privacy Policy.

News

Featured | 05.07.22

Press release: Breakthrough radiology AI provider annalise.ai appoints proven global healthcare leader as CEO, officially launches US team following FDA clearances

Press release Seasoned health technology executive Lakshmi Gudapakkam to become CEO and former HCA Healthcare, Inc. executive Dr Rick Abramson appointed as Chief Medical Officer. […]
Read more
1/3
Featured | 06.05.22

Annalise Enterprise CXR Named “Best New Radiology Solution” in 2022 MedTech Breakthrough Awards Program

Annalise Enterprise CXR has been recognised as the winner of the “Best New Radiology Solution” award in the sixth annual MedTech Breakthrough Awards program conducted […]
Read more
2/3
Featured | 14.03.22

Annalise Enterprise CXR receives first U.S. FDA 510(k) clearance

We are excited to share that we have received the first U.S. FDA 510(k) clearance for our Annalise Enterprise CXR solution.  This CADt FDA clearance […]
Read more
3/3
1/3
3 results
11.06.21
Mitigating shortcut learning and measuring the true performance of AI in medical imaging
As artificial intelligence for medical imaging increases in adoption, the need for careful evaluation of the true performance of these algorithms has become more urgent. […]
Annalise CXR, Artificial intelligence
03.05.21
How to evaluate a diagnostic radiology AI paper?
As artificial intelligence enters practical and daily use, radiologists will increasingly engage with radiology AI algorithms as end-users or stakeholders in deciding whether to implement algorithms in clinical practice. As radiologists, […]
Artificial intelligence, Clinical research, Data
26.04.21
Published Clinical Poster: Designing Effective Artificial Intelligence Software
Annalise CXR, Artificial intelligence, Clinical research
Never miss an update

Subscribe to receive first access to research, white-papers, webinars and news.